These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1911189)

  • 1. 31P nuclear magnetic resonance spectroscopy, histology and cytokinetics of a xenografted hypopharynx carcinoma following treatment with cisplatin: comparison in three sublines with increasing resistance.
    Tausch-Treml R; Köpf-Maier P; Baumgart F; Gewiese B; Ziessow D; Scherer H; Wolf KJ
    Br J Cancer; 1991 Sep; 64(3):485-93. PubMed ID: 1911189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 31P NMR spectroscopy of a xenografted hypopharynx carcinoma: effects of tumor growth and treatment with cisplatin on the tumor phosphorus metabolism, histology and cytokinetics.
    Tausch-Treml R; Baumgart F; Ziessow D; Köpf-Maier P
    NMR Biomed; 1992; 5(3):127-36. PubMed ID: 1642969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 31P NMR study of cisplatin- and doxorubicin-induced changes in tumour metabolism in rats with a cisplatin-sensitive or -resistant immunocytoma.
    Sijens PE; van Echteld CJ; van Rijssel RH; Lagendijk JJ; Neijt JP; de Jong WH; van der Minnen AC; de Groot G; Seijkens D
    NMR Biomed; 1990 Jun; 3(3):124-31. PubMed ID: 2386659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of 31P NMR spectroscopy in predicting the response of a xenografted human hypopharynx carcinoma to irradiation.
    Jäckel MC; Köpf-Maier P; Baumgart F; Ziessow D; Tausch-Treml R
    J Cancer Res Clin Oncol; 2000 Jun; 126(6):325-31. PubMed ID: 10870642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo 31P magnetic resonance spectroscopy and 1H magnetic resonance imaging of human bladder carcinoma on nude mice: effects of tumour growth and treatment with cis-dichloro-diamine platinum.
    De Certaines JD; Albrectsen J; Larsen VA; Xie X; Rygaard J; Henriksen O
    In Vivo; 1992; 6(6):611-6. PubMed ID: 1296810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 31P-nuclear magnetic resonance spectroscopy in vivo of six human melanoma xenograft lines: tumour bioenergetic status and blood supply.
    Lyng H; Olsen DR; Southon TE; Rofstad EK
    Br J Cancer; 1993 Dec; 68(6):1061-70. PubMed ID: 8260356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation.
    Lyng H; Olsen DR; Petersen SB; Rofstad EK
    NMR Biomed; 1995 Apr; 8(2):65-71. PubMed ID: 7547188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-31 changes as a measure of therapy response in resistant and sensitive osteosarcomas implanted into nude mice.
    Ballinger JR; Kang H; Sweeney CA; Scott JD; Croker BP; Scott KN
    Magn Reson Imaging; 1995; 13(6):877-83. PubMed ID: 8544659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acquired cisplatin resistance on the response of a xenografted human hypopharynx carcinoma to concurrent radiochemotherapy with cisplatin.
    Jäckel M; Tausch-Treml R; Köpf-Maier P
    Laryngoscope; 1994 Mar; 104(3 Pt 1):329-34. PubMed ID: 8127191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cisplatin on cell-cycle progression in xenografted human head and neck carcinomas.
    Jäckel M; Köpf-Maier P
    Cancer Chemother Pharmacol; 1991; 27(6):464-71. PubMed ID: 2013116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification.
    Bremner JC; Counsell CJ; Adams GE; Stratford IJ; Wood PJ; Dunn JF; Radda GK
    Br J Cancer; 1991 Nov; 64(5):862-6. PubMed ID: 1931606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in the ATP signal after treatment with cisplatin in two different cell lines studied by 31P NMR spectroscopy.
    Berghmans K; Ruiz-Cabello J; Simpkins H; Andrews PA; Cohen JS
    Biochem Biophys Res Commun; 1992 Feb; 183(1):114-20. PubMed ID: 1543482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo model development of cisplatin-resistant and -sensitive A2780 human ovarian carcinomas.
    Rose WC; Basler GA
    In Vivo; 1990; 4(6):391-6. PubMed ID: 2103379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterization of cisplatin-resistant human epidermoid carcinoma cell line, A431 cell.
    Mese H; Sasaki A; Alcalde RE; Nakayama S; Matsumura T
    Chemotherapy; 1998; 44(6):414-20. PubMed ID: 9755302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of resistance to cisplatin is associated with decreased expression of the gp185c-erbB-2 protein and alterations in growth properties and responses to therapy in an ovarian tumor cell line.
    Langton-Webster BC; Xuan JA; Brink JR; Salomon DS
    Cell Growth Differ; 1994 Dec; 5(12):1367-72. PubMed ID: 7696185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
    Kjellén E; Wennerberg J; Pero R
    Br J Cancer; 1989 Feb; 59(2):247-50. PubMed ID: 2930689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of the anticancer agent cisplatin in the treatment of human cervical squamous carcinoma xenografted in nude mice.
    Pillay CV; Green-Thompson R; Brock-Utne JG
    Chemotherapy; 1986; 32(4):356-63. PubMed ID: 3731921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
    Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
    Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth studies of subcutaneous rat tumours: comparison of 31P-NMR spectroscopy, acid extracts and histology.
    Stubbs M; Rodrigues LM; Griffiths JR
    Br J Cancer; 1989 Nov; 60(5):701-7. PubMed ID: 2803946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 31P NMR spectroscopy measurements of human ovarian carcinoma xenografts: relationship to tumour volume, growth rate, necrotic fraction and differentiation status.
    Rofstad EK; DeMuth P; Sutherland RM
    Radiother Oncol; 1988 Aug; 12(4):315-26. PubMed ID: 3187070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.